Literature DB >> 8872866

Influence of nicardipine, nimodipine and flunarizine on the anticonvulsant efficacy of antiepileptics against pentylenetetrazol in mice.

M Gasior1, R Kamiński, T Brudniak, Z Kleinrok, S J Czuczwar.   

Abstract

Among three calcium channel inhibitors, only nicardipine (10-40 mg/kg) significantly inhibited clonic seizures induced by pentylenetetrazol administered at its CD97 (convulsive dose 97%) of 81 mg/kg, subcutaneously. Nimodipine and flunarizine (both up to 80 mg/kg) did not suppress pentylenetetrazol-induced clonic seizures per se. Co-administration of nicardipine (5 mg/kg) resulted in a significant enhancement of the protective potency of either ethosuximide (50 mg/kg) or valproate (100 mg/kg) against clonic seizures in this test. Similar effects were noted in case of combined treatment of nimodipine (20-40 mg/kg) with these antiepileptics. On the contrary, flunarizine (up to 20 mg/kg) did not modify the anticonvulsive action of these antiepileptic drugs. Moreover, none of the studied calcium channel inhibitors influenced the protective activity of clonazepam (0.01 mg/kg). The antiepileptic drugs, administered alone in above doses, were ineffective against pentylenetetrazol-induced clonic convulsions. In case of ethosuximide and valproate, the motor performance in the chimney test was worsened by co-administration of nimodipine (40 mg/kg). We found no pharmacokinetic interactions (at least in relation to the plasma levels of ethosuximide and valproate) that could explain the observed results. Thus, we conclude that a combination of some calcium channel inhibitors and antiepileptic drugs may provide more efficient protection against experimental seizures which may bear a potential clinical significance.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8872866     DOI: 10.1007/BF01273360

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  36 in total

1.  Some central pharmacological effects of the calcium channel antagonist flunarizine.

Authors:  A Czyrak; E Mogilnicka; J Maj
Journal:  J Neural Transm Gen Sect       Date:  1991

2.  Effects of calcium channel inhibitors upon the efficacy of common antiepileptic drugs.

Authors:  S J Czuczwar; A Chodkowska; Z Kleinrok; U Małek; E Jagiełło-Wójtowicz
Journal:  Eur J Pharmacol       Date:  1990-01-25       Impact factor: 4.432

3.  Anticonvulsant effects of some calcium entry blockers in DBA/2 mice.

Authors:  G B De Sarro; B S Meldrum; G Nisticó
Journal:  Br J Pharmacol       Date:  1988-02       Impact factor: 8.739

4.  Influence of calcium channel inhibitors upon the anticonvulsant efficacy of common antiepileptics against pentylenetetrazol-induced convulsions in mice.

Authors:  S J Czuczwar; U Małek; Z Kleinrok
Journal:  Neuropharmacology       Date:  1990-10       Impact factor: 5.250

5.  Involvement of pentylenetetrazole in synapsin I phosphorylation associated with calcium influx in synaptosomes from rat cerebral cortex.

Authors:  M Onozuka; S Imai; S Ozono
Journal:  Biochem Pharmacol       Date:  1987-05-01       Impact factor: 5.858

6.  Double-blind placebo-controlled trial of flunarizine as add-on therapy in epilepsy.

Authors:  J Overweg; C D Binnie; J W Meijer; H Meinardi; S T Nuijten; S Schmaltz; A Wauquier
Journal:  Epilepsia       Date:  1984-04       Impact factor: 5.864

Review 7.  Contribution of calcium ions to the generation of epileptic activity and antiepileptic calcium antagonism.

Authors:  E J Speckmann; H Straub; R Köhling
Journal:  Neuropsychobiology       Date:  1993       Impact factor: 2.328

8.  Inhibition of [3H]dopamine uptake by flunarizine.

Authors:  P Devoto; L Pani; A Kuzmin; G De Montis
Journal:  Eur J Pharmacol       Date:  1991-10-02       Impact factor: 4.432

Review 9.  Some aspects of prognosis in the epilepsies: a review.

Authors:  J W Sander
Journal:  Epilepsia       Date:  1993 Nov-Dec       Impact factor: 5.864

10.  Interaction of flunarizine with dopamine D2 and D1 receptors.

Authors:  C Ambrosio; E Stefanini
Journal:  Eur J Pharmacol       Date:  1991-05-17       Impact factor: 4.432

View more
  4 in total

1.  Experimental re-evaluation of flunarizine as add-on antiepileptic therapy.

Authors:  Anamika Thakur; A K Sahai; J S Thakur
Journal:  J Pharm Bioallied Sci       Date:  2011-04

2.  Ketamine and its combinations with valproate and carbamazepine are ineffective against convulsions induced by atropine treatment and food intake in fasted mice.

Authors:  Neriman Gözüaçık; Aslı Zengin Türkmen; Asiye Nurten; Nurhan Enginar
Journal:  Iran J Basic Med Sci       Date:  2019-03       Impact factor: 2.699

3.  The Oxford study of Calcium channel Antagonism, Cognition, Mood instability and Sleep (OxCaMS): study protocol for a randomised controlled, experimental medicine study.

Authors:  Lauren Z Atkinson; Lucy Colbourne; Alexander Smith; Catherine H Harmer; Anna C Nobre; Jennifer Rendell; Helen Jones; Christopher Hinds; Arne Mould; Elizabeth M Tunbridge; Andrea Cipriani; John R Geddes; Kate E A Saunders; Paul J Harrison
Journal:  Trials       Date:  2019-02-12       Impact factor: 2.279

4.  Anti-neuroinflammatory effects of the calcium channel blocker nicardipine on microglial cells: implications for neuroprotection.

Authors:  Bor-Ren Huang; Pei-Chun Chang; Wei-Lan Yeh; Chih-Hao Lee; Cheng-Fang Tsai; Chingju Lin; Hsiao-Yun Lin; Yu-Shu Liu; Caren Yu-Ju Wu; Pei-Ying Ko; Shiang-Suo Huang; Horng-Chaung Hsu; Dah-Yuu Lu
Journal:  PLoS One       Date:  2014-03-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.